1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69DAFA587FBAFB3C700258B2D003BFD48
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-building-a-foundational-global-function-for-reviewing-ime-grants-technology-structure-resources?opendocument
18
19opendocument
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Education

Building a Foundational Global Function for Reviewing IME Grants: Technology, Structure, and Resources

ID: 5807


Features:

7 Info Graphics

11 Data Graphics

110+ Metrics

49 Narratives


Pages/Slides: 26


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Building a Foundational Global Function for Reviewing IME Grants: Technology, Structure, and Resources”

STUDY OVERVIEW

Independent Medical Education (IME) Grants programs offer biopharma organizations a distinctive avenue to back high-quality, evidence-based educational endeavors for healthcare professionals, patients, payers, and systems globally. Consequently, leveraging advanced technologies and optimizing organizational structure and resources become crucial for maximizing the effectiveness and impact of IME grants.

Best Practices, LLC conducted this benchmarking research to explore innovative systems, structures, and resources essential for building a foundational global function for reviewing IME grants. The study also examines IME performance metrics, field medical support, and top future trends and lessons learned.

KEY TOPICS

  • IME Grants Review Systems
  • Staffing Levels and Budget Allocation for IME Grants
  • IME Performance
  • Field Medical Support for IME
  • Future Trends and Lessons Learned

KEY METRICS

  • Software platforms employed by Medical Education teams for grant evaluation and management, including duration of use
  • Work streams and functions granted shared access to the system
  • Deployment of field medical staff to aid in distributing invitations for company-sponsored IME programs
  • Key strengths and top improvement areas in current IME performance
  • IME grants budget allocation across key markets
  • Teams accountable for core activities in the grants review process
  • Organizational alignment of global IME staff members
  • Staffing levels for global IME groups
  • Proportion of time dedicated to IME activities
  • Top lessons for managing an effective and impactful grants program

SAMPLE KEY FINDINGS

  • Current IME Performance: Measuring performance/outcomes is a top improvement area among IME groups, with 90% of organizations reporting that improvement in this area is needed.

METHODOLOGY

Best Practices, LLC conducted a comprehensive benchmarking survey involving 13 Medical leaders from 13 companies across 22 therapeutic areas. Follow-up interviews were conducted to delve deeper into the data and approaches described. Most participants represented mid-cap biopharma organizations.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Alexion Pharmaceuticals; Alkermes; Astellas; Baxter International; Dermavant Sciences; GRAIL; Grifols; Merck; OTSUKA; Sage Therapeutics; Sanofi; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.